VarDecrypt

VarDecrypt analyzes whole-exome sequencing (WES) data to prioritize and functionally characterize gene variants for identifying causative variants and deregulated pathways in human disorders, including cancers.


Key Features:

  • Comprehensive filtering: Enables extensive filtering of genes and variants within WES datasets to focus analyses on relevant candidates.
  • Clustering and enrichment analysis: Performs clustering and pathway/enrichment analyses to identify significant patterns and affected pathways.
  • Variant prioritization: Ranks and prioritizes gene variants to support selection of candidates for downstream functional studies.
  • High-throughput WES analysis: Processes and interprets high-throughput whole-exome sequencing data to facilitate discovery of causative gene variants.

Scientific Applications:

  • Acute erythroid leukemia analysis: Applied to a cohort of 10 patients with acute erythroid leukemia to identify known oncogenes and suggest novel potential driver genes.
  • Multiple myeloma validation: Validated on an independent dataset of approximately 90 multiple myeloma WES cases to confirm identification of deregulated genes and pathways.

Methodology:

Analyzes whole-exome sequencing (WES) high-throughput data using gene and variant filtering, clustering, enrichment analyses, and variant prioritization to identify causative gene variants.

Topics

Details

Cost:
Free of charge
Tool Type:
web application
Operating Systems:
Mac, Linux, Windows
Programming Languages:
R
Added:
1/22/2024
Last Updated:
11/24/2024

Operations

Publications

Salma M, Alaterre E, Moreaux J, Soler E. Var∣Decrypt: a novel and user-friendly tool to explore and prioritize variants in whole-exome sequencing data. Epigenetics & Chromatin. 2023;16(1). doi:10.1186/s13072-023-00497-4. PMID:37312221. PMCID:PMC10265870.

PMID: 37312221
Funding: - Agence Nationale de la Recherche: AAPG 2022 - PRC – ZEBERY, ANR-11-LABX-0051, ANR-18-IDEX-0001, ANR-18-CE15-0010-01 PLASMADIFF-3D - Fondation pour la Recherche Médicale: FRM DEQ20180339221

Links